Interstitial Lung Disease & Sarcoidosis
Reading HRCT patterns, spotting exposures, and cracking sarcoidosis
Recognizing ILD and building the workup
Clinical picture. Interstitial lung disease (ILD) causes exertional dyspnea and a dry cough. On exam there are fine, "Velcro" inspiratory crackles at the bases, and some patients have clubbing.
Restrictive physiology. Fibrosis makes the lungs small and stiff. FVC and TLC fall, but the FEV1/FVC ratio is preserved or even high, because stiff lungs recoil well and both values fall together. The thickened interstitium impairs gas transfer, so DLCO is reduced.
| Measure | Restrictive (ILD) | Obstructive (COPD) |
|---|---|---|
| TLC | Low | High (hyperinflation) |
| FEV1/FVC | Normal or high | <0.7 |
| DLCO | Reduced (impaired diffusion) | Low or normal (airflow is the problem) |
Workup.
- Take a detailed occupational, exposure, and drug history. Drugs that cause ILD include amiodarone, bleomycin, methotrexate, and nitrofurantoin.
- HRCT to identify the pattern
- PFTs with DLCO
- Serologies for connective tissue disease: ANA, RF, myositis panel
- Bronchoscopy with bronchoalveolar lavage (BAL) or biopsy when the diagnosis is still unclear
IPF and connective-tissue-disease ILD
Idiopathic pulmonary fibrosis (IPF). Typically affects older men, often smokers, with progressive dyspnea over months to years. HRCT shows a usual interstitial pneumonia (UIP) pattern: subpleural, basal-predominant reticulation, traction bronchiectasis, and honeycombing. In the right clinical setting, a definite UIP pattern establishes IPF without a surgical lung biopsy. Median survival is only 3–5 years.
Treating IPF. The antifibrotics pirfenidone and nintedanib slow the decline in FVC but do not reverse fibrosis. Give supplemental oxygen for hypoxemia. Lung transplant is the only definitive therapy.
Immunosuppression harms patients with IPF. In the PANTHER-IPF trial, prednisone plus azathioprine plus N-acetylcysteine increased mortality.
Connective-tissue-disease ILD. Systemic sclerosis (scleroderma) is the most common and deadliest association, usually with a nonspecific interstitial pneumonia (NSIP) pattern. Other associations are rheumatoid arthritis, dermatomyositis and antisynthetase syndrome (anti-Jo-1), SLE, and Sjögren syndrome.
| Feature | UIP (IPF pattern) | NSIP |
|---|---|---|
| HRCT | Subpleural, basal reticulation; traction bronchiectasis; honeycombing | Uniform ground-glass, often lower lobe; no honeycombing |
| Typical setting | Idiopathic, older male smoker | Connective tissue disease (especially scleroderma) |
| Steroids and immunosuppression | Not effective (harmful in IPF) | More responsive |
| Main therapy | Antifibrotics, oxygen, transplant | Immunosuppression |
Exposure-related disease: hypersensitivity pneumonitis and pneumoconioses
Hypersensitivity pneumonitis. An immune reaction to inhaled organic antigens. Examples are bird-fancier's lung (avian proteins) and farmer's lung (thermophilic actinomycetes in moldy hay). Acute episodes cause fever, cough, and dyspnea hours after exposure. The chronic form causes upper-lobe fibrosis. Treatment is antigen avoidance, with steroids for acute or severe disease.
Pneumoconioses. Fibrosis from inhaled inorganic dust. Remember the zones: asbestos affects the lower lobes, while silica, coal, and beryllium affect the upper lobes.
| Dust | Exposure | Zone | Hallmarks |
|---|---|---|---|
| Asbestos | Shipbuilding, roofing, insulation, old plumbing | Lower lobes | Calcified pleural plaques; ferruginous bodies; bronchogenic carcinoma (more common) and mesothelioma after a 20–40 year latency |
| Silica | Sandblasting, mining, quarrying, stone-cutting | Upper lobes | Nodules; eggshell calcification of hilar nodes; high risk of TB and other mycobacteria |
| Coal dust | Coal mining | Upper lobes | Macules; with rheumatoid arthritis = Caplan syndrome |
| Beryllium | Aerospace, electronics, nuclear industries | Upper lobes | Noncaseating granulomas that mimic sarcoidosis |
Silica and TB. Silica impairs macrophage function, so silicosis markedly increases the risk of tuberculosis and other mycobacterial infections. Screen with a PPD or IGRA.
Asbestos and smoking multiply each other's risk: together they raise bronchogenic carcinoma risk far more than either alone. Bronchogenic carcinoma remains more common than mesothelioma in asbestos-exposed patients.
Sarcoidosis: presentation and diagnosis
The disease. Sarcoidosis is a systemic disease of noncaseating granulomas. The classic patient is a young Black woman with bilateral hilar lymphadenopathy on chest x-ray. The lungs are involved in most patients, and the disease is restrictive when it involves the parenchyma.
- Eyes: uveitis
- Skin: erythema nodosum; lupus pernio (violaceous plaques on the nose and cheeks)
- Nerves: cranial nerve VII (facial) palsy
- Heart: conduction block (a cause of sudden death)
- Calcium: hypercalcemia, hypercalciuria, kidney stones
Diagnosis. Serum ACE is often elevated but nonspecific, so it neither confirms nor excludes the diagnosis. Biopsy, often by bronchoscopy of hilar nodes, shows noncaseating granulomas. Stains and cultures must exclude TB and fungal infection, which also form granulomas. BAL typically shows lymphocytosis with a high CD4:CD8 ratio.
Scadding stages (chest x-ray). Stage 0 is a normal film. Stage I is hilar adenopathy alone. Stage II is adenopathy plus parenchymal infiltrates. Stage III is infiltrates without adenopathy. Stage IV is fibrosis.
Sarcoidosis: hypercalcemia, Löfgren syndrome, and treatment
- Granuloma macrophagesExpress 1α-hydroxylase, without regulation by PTH.
- 25-OH vitamin D → 1,25-(OH)2 vitamin DActive calcitriol is produced.
- Gut calcium absorption risesPTH becomes suppressed.
- Hypercalcemia and hypercalciuriaKidney stones.
In sarcoid hypercalcemia, PTH is low. The calcium comes from unregulated calcitriol, not from PTH or PTHrP. Glucocorticoids correct it by suppressing granuloma 1α-hydroxylase.
Löfgren syndrome. An acute presentation of sarcoidosis with a good prognosis and a high rate of spontaneous remission. The triad is erythema nodosum, bilateral hilar adenopathy, and migratory polyarthralgias, often with fever. NSAIDs are frequently the only treatment needed.
Who gets treated. Many cases remit spontaneously, so asymptomatic hilar adenopathy (stage I) is usually just observed. Give systemic corticosteroids for symptomatic or progressive pulmonary disease, or for organ-threatening involvement:
- Cardiac
- Neurologic
- Ocular
- Hypercalcemia
Methotrexate is the usual steroid-sparing agent. An elevated ACE level alone is never a reason to treat.